Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | |
|---|---|---|---|---|---|
| Revenue | $10.1B | $10.5B | $9.7B | $9.0B | $9.3B |
| YoY growth | +8.2% | +9.3% | +5.9% | +7.7% | +0.2% |
| Gross margin | 27.8% | 28.2% | 26.8% | 32.7% | 26.1% |
| Operating margin | 8.0% | 9.1% | 7.6% | 13.0% | 7.3% |
| Net income | $560M | $665M | $743M | $641M | $402M |
| Diluted EPS | 0.44 | 0.52 | 0.57 | 0.49 | 0.31 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
Similar than in the previous 10-Q (2026-04-28: +7, +4 points)
10-Q of 2026-07-28 · 32.3% positive sentences, 20.0% negative · 390 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier |
0.0% | $4.4M | = |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for MDLZ →
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.